Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.

Atherosclerosis - 1 Sept 2005

Tiroch K, von Beckerath N, Koch W, Lengdobler J, Joost A, Schömig A, Kastrati A

Abstract excerpt

In a recent study, analysis of gene expression in atherectomy specimens derived from restenotic coronary lesions revealed 223 differentially expressed genes. Thirty-seven of these genes indicated activation of interferon- (IFN-) gamma signaling in neointimal smooth muscle cells. Moreover, genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Restenosis
Share to Coronary Stenosis
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-gamma

Share to Interferon gamma Receptor

Share to Postoperative Complications

Share to Receptors, Interferon

Share to Stents

Source

Identifiers

PMID: 16115485
DOI: 10.1016/j.atherosclerosis.2005.02.003

Genes

IFNG
IFNGR1
IFNGR2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16115485-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.PMID 16115485Read ↗

Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.Semantic proximity Read ↗

Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.Semantic proximity Read ↗

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.Semantic proximity Read ↗

Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.Semantic proximity Read ↗

Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.Semantic proximity Read ↗

The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.Semantic proximity Read ↗

Candidate genetic markers and the risk of restenosis after coronary angioplasty.Semantic proximity Read ↗

Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.Semantic proximity Read ↗

Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting.Semantic proximity Read ↗

Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.Semantic proximity Read ↗

The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.Semantic proximity Read ↗

Genetic risk of restenosis after percutaneous coronary interventions in the era of drug-eluting stents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.